The CTH is proud to announce that Dr. Stefano Barco is the winner of the Bayer Thrombosis Award 2021


The aim of the renowned Bayer Thrombosis Award is to support early career researchers excelling in thrombosis research. The scientific projects and high-impact publications of Dr. Barco convinced the jury that he is an outstanding clinician-scientist pursuing a most promising career as a future leader in the field.

Dr. Barco was nominated by the CTH for this honourable distinction. He worked at the CTH between 2015 and 2020, beginning as postdoctoral fellow and continuing as Junior Group leader. Last year he moved to University of Zurich, but remains an active member of the CTH. As a Visiting Scientist of the Centre, Stefano Barco continues to lead numerous research projects, multicentre trials and networks.

Dr. Barco will receive the Bayer Research Award at the 65th Annual Meeting of the Society of Thrombosis and Haemostasis Research (GTH). The online ceremony will take place on Friday 26 February 2021, at 16:30 hrs CET.

Welcome to the website of the CTH!


The Center for Thrombosis and Hemostasis Mainz (CTH) was established in 2010 as an Integrated Research and Treatment Center (IFB) funded by the German Ministry for Education and Research (BMBF). The CTH provides a unique interdisciplinary environment that facilitates basic research, innovative patient care and the development of new diagnostic approaches and therapies. The CTH fosters translational research from bedside-to-bench and vice versa in the field of thrombosis and hemostasis and career development of physician scientists and biomedical researchers.


On behalf of the CTH, we invite you to inform yourself about the different tasks and projects.


Professor Stavros Konstantinides, MD (Medical Director CTH)

Professor Wolfram Ruf, MD (Scientific Director CTH)

Dr. Jana Grünewald (General Manager CTH)




Executive Directors (f.l.t.r. Prof. Ruf, Prof. Konstantinides, Dr. Grünewald)


In July Dr. Kerstin Jurk published togehther with colleagues from Germany and Austria a study on 'Standardization of Light Transmission Aggregometry for Diagnosis of Platelet Disorders (Pdf-file, 183,3 KB)'.

ISTH 2019

Watch our CTH TV Clips at the ISTH 2019:

FXa Inhibitors Target FXa-PAR2 Signaling
PD Dr. Claudine Graf

Microbiota and Cardiovascular Risk
Jun.-Prof. Christoph Reinhardt